SNCA and Parkinson disease: Both 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-synuclein over-expression models of PD in monkeys also showed region-specific and long-term microglial activation in the SNpc (Kanaan et al., 2008; Barkholt et al., 2012).